U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H26N2O2.ClH
Molecular Weight 398.926
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXETIMIDE HYDROCHLORIDE

SMILES

Cl.O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C4=CC=CC=C4

InChI

InChIKey=XSOOSXRNMDUWEM-GNAFDRTKSA-N
InChI=1S/C23H26N2O2.ClH/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18;/h1-10,20H,11-17H2,(H,24,26,27);1H/t23-;/m1./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C23H26N2O2
Molecular Weight 362.4647
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Dexetimide is a potent central and peripheral anticholinergic agent. It has a high affinity for all subtypes of muscarinic receptor and a long duration action. It forms very stable complex with mAChR. Dexetimide was used for many years in Europe for the treatment of extrapyramidal disorders. Neuroleptic-induced parkinsonian symptoms are effectively controlled by dexetimide. It is a safe, potent, and long-acting antiparkinsonian agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
1971
Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
1973 Jul-Aug
Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists.
1985 Dec
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
1998 Feb

Sample Use Guides

Dosages ranged from 0.5 to 1.5 mg daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:20:03 UTC 2023
Edited
by admin
on Fri Dec 15 15:20:03 UTC 2023
Record UNII
B987A3XX7D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXETIMIDE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
Dexetimide hydrochloride [WHO-DD]
Common Name English
DEXETIMIDE HYDROCHLORIDE [MART.]
Common Name English
TREMBLEX
Brand Name English
R-16470
Code English
DEXETIMIDE HCL
Common Name English
R 16,470
Code English
DEXETIMIDE HYDROCHLORIDE [MI]
Common Name English
(S)-2-(1-BENZYL-4-PIPERIDYL)-2-PHENYLGLUTARIMIDE HYDROCHLORIDE
Systematic Name English
BENZETIMIDE HYDROCHLORIDE, (S)-
Common Name English
Code System Code Type Description
DRUG BANK
DBSALT002920
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
FDA UNII
B987A3XX7D
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
EVMPD
SUB23576
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
ECHA (EC/EINECS)
244-633-2
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
RXCUI
259361
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY RxNorm
PUBCHEM
30842
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
MERCK INDEX
m4217
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID50944485
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
CAS
21888-96-0
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
SMS_ID
100000089082
Created by admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
RACEMATE -> ENANTIOMER
Related Record Type Details
ACTIVE MOIETY